Shared genetic architecture and neurobiological pathways of problematic alcohol use and anxiety disorders
Open Access
- 13 July 2026
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- p. 1-11
Abstract
Problematic alcohol use (PAU) and anxiety disorders (ANX) frequently co-occur, implying shared genetic and neurobiological foundations. However, the directionality of potential causal relationships and the specific mechanisms underlying the overlap remain unclear. Thus, we investigated the shared genetic architecture and neurobiological pathways between PAU and ANX using a multimethod genomic approach. We analyzed summary statistics from genome-wide association studies (GWAS) of PAU and ANX using Mendelian Randomization to assess causal associations between ANX and PAU. We used MiXeR to assess the overall shared genomic architecture, Local Analysis of (co)Variant Association to estimate regional genetic correlations, and conjunctional false discovery rate (conjFDR) to identify individual overlapping loci. We used FUMA to map single-nucleotide polymorphisms (SNPs) to independent loci, conduct differential gene expression analyses across 30 general and 54 specific tissue types, and perform cell-type specificity analyses using a human brain cell atlas. Druggability of identified targets was also evaluated. Mendelian Randomization analyses indicated bidirectional causal associations between ANX and PAU. MiXeR identified moderate polygenic overlap (52.5%) and genetic correlation ( r g = 0.44) between the traits, with high effect direction concordance among shared estimated causal variants (86.4%). ConjFDR identified 97 shared lead SNPs, of which 89 had concordant and 8 discordant effects on PAU and ANX. These loci mapped to 97 genes, including DRD2 and PDE4B , genes linked to dopaminergic and cAMP signaling pathways, respectively. Concordant gene expression was enriched in brain, nerve, adrenal gland, esophagus, stomach, and colon, with enriched expression specifically in the prefrontal cortex, anterior cingulate cortex, hippocampus, hypothalamus, substantia nigra and amygdala. FUMA cell-type enrichment analysis identified associations predominantly in neurons from the cerebral cortex, hippocampus, and thalamus. We found substantial genetic and neurobiological overlap between PAU and ANX, highlighting reciprocal, causal relationships between the traits, with differentially expressed genes enriched in addiction- and anxiety-relevant brain regions. These findings support shared genetic and neurobiological mechanisms linking PAU and ANX, while acknowledging that some signals may reflect broader internalizing or psychiatric liability.Keywords
Funding Information
- National Institute of Mental Health (MH132337)
- National Institute on Alcohol Abuse and Alcoholism (R01 AA030056)
- National Institute on Alcohol Abuse and Alcoholism (AA030041)
This publication has 67 references indexed in Scilit:
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery, 2009
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtNature Protocols, 2009
- A role for GABA mechanisms in the motivational effects of alcoholBiochemical Pharmacology, 2004
- Risperidone reduces limited access alcohol drinking in alcohol-preferring ratsEuropean Journal of Pharmacology, 2003
- Addiction and its reward process through polymorphisms of the D2dopamine receptor gene: a reviewEuropean Psychiatry, 2000
- Efficacy of Buspirone in Alcohol Dependence: A ReviewAlcohol, Clinical and Experimental Research, 1996
- Buspirone Treatment of Anxious AlcoholicsArchives of General Psychiatry, 1994
- Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonistBrain Research Bulletin, 1993
- Overview of effects of theophyllineJournal of Allergy and Clinical Immunology, 1986